Identification of Highly Specific Diversity-Oriented Synthesis-Derived Inhibitors of Clostridium difficile
Authors:
- 7 March 2017
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Infectious Diseases
- Vol. 3 (5) , 349-359
Abstract
In 2013, the Centers for Disease Control highlighted Clostridium difficile as an urgent threat for antibiotic-resistant infections, in part due to the emergence of highly virulent fluoroquinolone-resistant strains. Limited therapeutic options currently exist, many of which result in disease relapse. We sought to identify molecules specifically targeting C. difficile in high-throughput screens of our diversity-oriented synthesis compound collection. We identified two scaffolds with apparently novel mechanisms of action that selectively target C. difficile while having little to no activity against other intestinal anaerobes; preliminary evidence suggests that compounds from one of these scaffolds target the glutamate racemase. In vivo efficacy data suggest that both compound series may provide lead optimization candidates.Keywords
Funding Information
- National Institute of Allergy and Infectious Diseases (HHSN272200900018C, U19 AI110818)
- Broad Institute of MIT and Harvard
This publication has 31 references indexed in Scilit:
- Pilon: An Integrated Tool for Comprehensive Microbial Variant Detection and Genome Assembly ImprovementPLOS ONE, 2014
- Diversity-Oriented Synthesis Probe TargetsPlasmodium falciparumCytochrome b Ubiquinone Reduction Site and Synergizes With Oxidation Site InhibitorsThe Journal of Infectious Diseases, 2014
- Fecal microbiota transplantation: a new standard treatment option forClostridium difficileinfectionExpert Review of Anti-infective Therapy, 2013
- Clostridium difficile: Changing Epidemiology, Treatment and Infection Prevention MeasuresCurrent Infectious Disease Reports, 2012
- Application of a Sparse Matrix Design Strategy to the Synthesis of DOS LibrariesACS Combinatorial Science, 2011
- Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical SuccessJournal of Medicinal Chemistry, 2009
- Drugs for bad bugs: confronting the challenges of antibacterial discoveryNature Reviews Drug Discovery, 2006
- Extra Precision Glide: Docking and Scoring Incorporating a Model of Hydrophobic Enclosure for Protein−Ligand ComplexesJournal of Medicinal Chemistry, 2006
- A hierarchical approach to all‐atom protein loop predictionProteins: Structure, Function, and Bioinformatics, 2004
- Antibiotic-Associated Pseudomembranous Colitis Due to Toxin-Producing ClostridiaNew England Journal of Medicine, 1978